These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33382789)

  • 1. Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: In-vitro optimization/in-vivo evaluation.
    Fouad SA; Malaak FA; El-Nabarawi MA; Abu Zeid K
    PLoS One; 2020; 15(12):e0244646. PubMed ID: 33382789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and optimization of osmotically controlled drug delivery system for poorly aqueous soluble diacerein to improve its bioavailability.
    Mohamed MI; Al-Mahallawi AM; Awadalla SM
    Drug Dev Ind Pharm; 2020 May; 46(5):814-825. PubMed ID: 32306779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Deliv; 2016 Oct; 23(8):2998-3007. PubMed ID: 26828616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diacerein solid dispersion loaded tablets for minimization of drug adverse effects: statistical design, formulation,
    Soliman MAN; Ibrahim HK; Nour SAE
    Pharm Dev Technol; 2021 Mar; 26(3):302-315. PubMed ID: 33356729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein.
    Eltobshi AA; Mohamed EA; Abdelghani GM; Nouh AT
    Int J Nanomedicine; 2018; 13():6585-6602. PubMed ID: 30425476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study.
    Teaima MH; Abdel-Haleem KM; Osama R; El-Nabarawi MA; Elnahas OS
    Drug Des Devel Ther; 2021; 15():4229-4242. PubMed ID: 34675486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling.
    Fouad SA; Malaak FA; El-Nabarawi MA; Abu Zeid K; Ghoneim AM
    PLoS One; 2021; 16(1):e0245482. PubMed ID: 33471832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
    Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
    Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
    Elsayed I; Abdelbary AA; Elshafeey AH
    Int J Nanomedicine; 2014; 9():2943-53. PubMed ID: 24971006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
    Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
    AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of lyophilized orally disintegrating tablets using factorial design.
    Ahmed IS; Shamma RN; Shoukri RA
    Pharm Dev Technol; 2013; 18(4):935-43. PubMed ID: 22107175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients.
    Conceição J; Adeoye O; Cabral-Marques H; Concheiro A; Alvarez-Lorenzo C; Sousa Lobo JM
    AAPS PharmSciTech; 2020 Jan; 21(2):39. PubMed ID: 31897724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
    Moqbel HA; ElMeshad AN; El-Nabarawi MA
    Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats.
    Fouad SA; Teaima MH; Gebril MI; Abd Allah FI; El-Nabarawi MA; Elhabal SF
    Drug Deliv; 2023 Dec; 30(1):2181747. PubMed ID: 36803255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization.
    Agiba AM; Abdel-Hamid S; Nasr M; Geneidi AS
    Curr Drug Deliv; 2018 Feb; 15(2):267-277. PubMed ID: 28322163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin.
    Salmani JM; Lv H; Asghar S; Zhou J
    Pharm Dev Technol; 2015 Jun; 20(4):465-72. PubMed ID: 24490758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.